Florida Paramedics Are Handing Out Buprenorphine at the Scene. It's Working.
A model that meets people in the worst moment of their lives — and doesn't make them wait until the worst is over to start treatment.
There is a version of addiction treatment that has, for decades, operated on a particular theory: that a person has to want to get better first, and then they can begin. The waiting room, the intake appointment, the 72-hour hold after an overdose before a bed becomes available — the system was designed around a window that might open, if circumstances aligned, if motivation held, if the person in question was lucky enough to be alive when the window did.
Florida counties are testing a different theory. In several jurisdictions, emergency medical services personnel — paramedics responding to overdose calls, wellness checks, and requests for medical assistance — have been trained and authorized to distribute buprenorphine directly at the scene. A person who overdoses and is revived is not stabilized and sent away with a pamphlet. They are offered medication, on the spot, in the moment when naloxone has just pulled them back from the edge.
KFF Health News reported this week on the real-world outcomes that Florida has started accumulating. The short version: it’s working. Patients who are offered buprenorphine in the field are more likely to follow up with treatment than patients who are simply referred. The skepticism that this approach would be refused or ignored — that people in the acute aftermath of an overdose wouldn’t or couldn’t consent to beginning medication-based treatment — has not matched what Florida EMS personnel are actually seeing.
The clinical rationale is well-established. Buprenorphine, administered early after an overdose when a patient is in precipitated withdrawal or early-stage active withdrawal, is among the most effective moments to initiate it. The discomfort of withdrawal is a powerful motivator. The medication addresses that discomfort immediately and begins changing the brain’s opioid receptor balance within hours. What would otherwise be a crisis moment becomes, in this model, the opening of a treatment window — not closed, opened.
This model requires several things that are not free: training for EMS personnel, a protocol signed off by a medical director, the legal infrastructure to allow paramedics to administer what is technically a Schedule III controlled substance (DEA rules do allow this with appropriate medical authorization), and a warm handoff system that connects patients who start buprenorphine in the field to a physician who can continue prescribing. Florida counties that have built that infrastructure report better results than counties that have not.
For Arizona, the implications are direct. Arizona’s overdose rates remain above the national average. The emergency department is the most common point of first contact with the treatment system for people in active crisis — and it is a point of contact that historically has not included immediate medication initiation. The EMS model doesn’t require building a new clinic. It requires training the people who are already showing up.
The skepticism about this approach — that people aren’t ready, that they won’t follow through, that EMS isn’t the right setting — is not supported by the Florida data. The window opens in the worst moments. The question is whether the system has anything to hand through it.
Sources Cited
- 01.B
- 02.A
Filed Under
treatmentharm-reductiontrends
Keep up with the reporting.
One email each morning with the stories that put days like this in context.
Continue reading
More from this section
The Seven-in-a-Hundred Problem: Alcohol Kills as Many Americans as Fentanyl, and 93 Percent Never Get Treatment
Alcohol kills roughly 105,000 Americans per year. Only 7% of people with alcohol use disorder ever receive treatment. A new class of medications — GLP-1 receptor agonists — shows the clearest efficacy signal in decades. The obstacles to reaching the other 93% are not scientific.
Treatment & RecoveryFor the First Time in Decades, Stimulants Kill More Americans Than Opioids. The Treatment System Has No Answer.
Stimulant deaths now surpass opioid-only overdoses. But the treatment system has no FDA-approved medication for meth or cocaine — and the one intervention that works, contingency management, is barely funded.
Treatment & RecoveryYour Pharmacist Can Now Prescribe Buprenorphine. That's a Bigger Deal Than It Sounds.
The SUPPORT Act of 2025 allows pharmacists to prescribe buprenorphine. Combined with permanent telehealth authorization and WHO updated guidelines, the access picture for OUD treatment has shifted.